NIM vs. BBH, NQP, MUA, HRZN, MYN, TYG, HQL, KTF, MCI, and SOR
Should you be buying Nuveen Select Maturities Municipal Fund stock or one of its competitors? The main competitors of Nuveen Select Maturities Municipal Fund include VanEck Biotech ETF (BBH), Nuveen Pennsylvania Quality Municipal Income Fund (NQP), BlackRock MuniAssets Fund (MUA), Horizon Technology Finance (HRZN), BlackRock MuniYield New York Quality Fund (MYN), Tortoise Energy Infrastructure (TYG), Abrdn Life Sciences Investors (HQL), DWS Municipal Income Trust (KTF), Barings Corporate Investors (MCI), and Source Capital (SOR). These companies are all part of the "investment offices, not elsewhere classified" industry.
Nuveen Select Maturities Municipal Fund (NYSE:NIM) and VanEck Biotech ETF (NASDAQ:BBH) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations.
In the previous week, VanEck Biotech ETF had 2 more articles in the media than Nuveen Select Maturities Municipal Fund. MarketBeat recorded 3 mentions for VanEck Biotech ETF and 1 mentions for Nuveen Select Maturities Municipal Fund. VanEck Biotech ETF's average media sentiment score of 0.92 beat Nuveen Select Maturities Municipal Fund's score of 0.80 indicating that VanEck Biotech ETF is being referred to more favorably in the news media.
Nuveen Select Maturities Municipal Fund has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. Comparatively, VanEck Biotech ETF has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.
VanEck Biotech ETF received 38 more outperform votes than Nuveen Select Maturities Municipal Fund when rated by MarketBeat users.
Given VanEck Biotech ETF's higher probable upside, analysts plainly believe VanEck Biotech ETF is more favorable than Nuveen Select Maturities Municipal Fund.
32.2% of Nuveen Select Maturities Municipal Fund shares are owned by institutional investors. Comparatively, 32.1% of VanEck Biotech ETF shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Nuveen Select Maturities Municipal Fund pays an annual dividend of $0.31 per share and has a dividend yield of 3.5%. VanEck Biotech ETF pays an annual dividend of $0.71 per share and has a dividend yield of 0.4%.
Summary
VanEck Biotech ETF beats Nuveen Select Maturities Municipal Fund on 6 of the 8 factors compared between the two stocks.
Get Nuveen Select Maturities Municipal Fund News Delivered to You Automatically
Sign up to receive the latest news and ratings for NIM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuveen Select Maturities Municipal Fund Competitors List
Related Companies and Tools
